Navigation Links
ActiGraph Announces New Scientific Affairs and Data Management Division

ActiGraph, the leading provider of medical-grade wearable activity and sleep monitoring solutions for the global scientific community, announced today the establishment of a new Scientific Affairs and Data Management division. A primary focus of this new division is to foster and support scientific collaborations with ActiGraph’s academic and pharmaceutical industry partners to advance the development of meaningful clinical trial endpoints based on high-resolution raw accelerometry data.

Guided by the novel endpoint development framework released by the Clinical Trials Transformation Initiative (CTTI) in 2017, ActiGraph’s Scientific Affairs and Data Management division, headed by Director Tyler Guthrie, will facilitate joint research and development projects involving corporate partners and subject matter experts from within the company’s global network of over 1000 academic partners. With extensive accelerometry experience in a wide variety of specific chronic disease populations, ActiGraph’s academic subject matter experts bring a wealth of practical knowledge and analytic expertise to projects exploring new meaningful clinical endpoints and better ways to measure existing endpoints using accelerometry. ActiGraph is also exploring additional partnerships to develop clinical endpoints based on new methods, including artificial intelligence (AI) and machine learning.

“The Scientific Affairs and Data Management division was formed as a direct response to the growing need from pharmaceutical sponsors and CROs for scientifically validated digital endpoints,” said Jeff Arnett, ActiGraph CEO. "We have already been tapping into the expertise of our academic subject matter experts and internal scientific team for existing clinical trial projects. By establishing this focused division, we can accelerate the development, validation, and implementation of novel digital clinical endpoints that could improve future trials.”

ActiGraph’s announcement comes at a time when the use of digital tools to capture quantifiable measures of biology and health is rapidly increasing across the clinical trials landscape. “We are delighted that pioneering companies like ActiGraph are helping lead the way in the development and application of digital biomarkers to a wide range of clinical conditions,” said E. Ray Dorsey, M.D., Editor-and-Chief for the Digital Biomarkers scientific journal.

ActiGraph’s establishment of the Scientific Affairs and Data Management division precedes the upcoming launches of two new products within its clinical trials technology ecosystem. In August 2018, the company will release CentrePoint 3.0, a major update to its software platform that includes highly anticipated raw data analytic capabilities. In late Q3 2018, ActiGraph will launch the patient-centric CentrePoint Insight Watch, a triaxial accelerometry watch with a 30-day battery life, designed specifically for use in clinical drug trials. The CentrePoint Insight Watch captures continuous, high-resolution raw acceleration data and supports near real-time remote patient monitoring when used in combination with ActiGraph’s CentrePoint home data hub or mobile application.

About ActiGraph
ActiGraph is the leading provider of medical-grade physical activity and sleep monitoring solutions for the global scientific community. ActiGraph’s wearable actigraphy monitors and robust analytics platform have been widely used to quantify human movement in academic and population health research for nearly two decades. In recent years, the company’s monitoring solutions have been steadily adopted by biopharma and life sciences organizations seeking to capture real-world objective outcomes related to physical activity, mobility, and sleep behavior for patients enrolled in clinical trials.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related biology news :

1. Merck Animal Health announces Vetsulin
2. AAPS announces 2013 National Biotechnology Conference award winners
3. PLOS announces Accelerating Science Award Program
4. DFG announces recipients of 2013 Heinz Maier-Leibnitz Prize
5. Missouri Botanical Garden program announces collaboration with LHerboretum
6. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
7. Chiltern Announces The Promotion Of Alecia Barbee To VP, Global Biometrics
8. DigitalPersona Announces U.are.U Software Development Kit (SDK) for Android Applications
9. PatientStream announces the industrys first Multilingual family waiting room board
10. Wiley announces increase in Impact Factors
11. Xyngular Announces the Launch of its New Xyng Enhanced Formula
Post Your Comments:
(Date:6/11/2019)... ... June 12, 2019 , ... With a rapidly growing customer ... the Geneious Biologics platform as a premium hub for bioinformatics and computer programming ... “The Geneious team has done an excellent job accommodating our specific data, resulting ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... and solutions in the global health and medical technology market, announced that it ... Healthcare Navigation / Robotics Solution” award in the 2019 MedTech Breakthrough Awards program. ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... exclusive financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by ... pathology platform that provides services to more than one dozen hospitals and surgery ...
Breaking Biology News(10 mins):
(Date:5/22/2019)... YORK (PRWEB) , ... May 22, 2019 , ... ... has closed a $8 million Series A funding round co-led by Astanor Ventures ... Empire State Development Fund and iSelect Fund . The company has ...
(Date:5/15/2019)... ... May 16, 2019 , ... ... As a result, food and beverage products rely on these ingredients to create ... natural sounding label declarations. This paradigm shift triggers food formulators to seek out ...
(Date:5/8/2019)... ... ... Standing at 16.2 hands, Atlas is on the large side for a Quarter Horse. ... among other activities. When loping around a corner in late 2017, Atlas tripped and ... to only being able to walk. Fortunately Atlas’ owner, Kelly, sought the opinion of ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography ... is estimated that 6.3 million Americans will have glaucoma, with black Americans having ...
Breaking Biology Technology: